|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
ATE207080T1
(de)
|
1991-11-25 |
2001-11-15 |
Enzon Inc |
Multivalente antigen-bindende proteine
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
EP0739981A1
(en)
|
1995-04-25 |
1996-10-30 |
Vrije Universiteit Brussel |
Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
|
|
US7771951B2
(en)
|
2001-12-03 |
2010-08-10 |
Amgen Fremont Inc. |
Antibody categorization based on binding characteristics
|
|
US20030224000A1
(en)
*
|
2001-12-21 |
2003-12-04 |
Kokai-Kun John Fitzgerald |
Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
|
|
WO2008016729A1
(en)
|
2006-08-04 |
2008-02-07 |
Nastech Pharmaceutical Company Inc. |
Compositions for intranasal delivery of human insulin and uses thereof
|
|
RU2010127156A
(ru)
*
|
2007-12-06 |
2012-01-20 |
Дана-Фарбер Кэнсер Инститьют, Инк. (Us) |
Антитела против вируса гриппа и их применение
|
|
CA2761648C
(en)
|
2009-05-11 |
2019-03-12 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
|
|
KR101860963B1
(ko)
|
2010-04-23 |
2018-05-24 |
제넨테크, 인크. |
이종다량체 단백질의 생산
|
|
CN105490420B
(zh)
|
2010-06-25 |
2018-01-12 |
菲舍尔和佩克尔应用有限公司 |
马达转子、马达、包含该转子的电器和该转子的制造方法
|
|
US9534042B2
(en)
|
2010-09-03 |
2017-01-03 |
Fujita Health University |
Influenza virus-neutralizing antibody and screening method therefor
|
|
WO2012109363A2
(en)
*
|
2011-02-08 |
2012-08-16 |
The Johns Hopkins University |
Mucus penetrating gene carriers
|
|
US8961978B2
(en)
*
|
2011-07-14 |
2015-02-24 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza A viruses of phylogenetic group 1 and phylogenetic group 2 and influenza B viruses
|
|
AU2011373387B2
(en)
|
2011-07-18 |
2017-06-29 |
Institute For Research In Biomedicine |
Neutralizing anti-influenza A virus antibodies and uses thereof
|
|
RU2654567C2
(ru)
|
2011-10-11 |
2018-05-21 |
Дженентек, Инк. |
Улучшенная сборка биспецифических антител
|
|
EP2785737A2
(en)
|
2011-12-02 |
2014-10-08 |
AIMM Therapeutics B.V. |
Influenza a virus specific antibodies
|
|
SG11201805001UA
(en)
|
2016-01-13 |
2018-07-30 |
Medimmune Llc |
Method of treating influenza a
|
|
WO2018140456A1
(en)
|
2017-01-24 |
2018-08-02 |
Northwestern University |
Active low molecular weight variants of angiotensin converting enzyme 2 (ace2)
|
|
WO2018148447A1
(en)
|
2017-02-08 |
2018-08-16 |
Adimab, Llc |
Antibody heavy chain variable domains targeting the nkg2d receptor
|
|
US11254733B2
(en)
|
2017-04-07 |
2022-02-22 |
Icahn School Of Medicine At Mount Sinai |
Anti-influenza B virus neuraminidase antibodies and uses thereof
|
|
EP3625251A1
(en)
|
2017-05-15 |
2020-03-25 |
University Of Rochester |
Broadly neutralizing anti-influenza monoclonal antibody and uses thereof
|
|
US11780907B2
(en)
|
2018-01-26 |
2023-10-10 |
Regeneron Pharmaceuticals, Inc. |
Human antibodies to influenza hemagglutinin
|
|
WO2019169231A1
(en)
|
2018-03-02 |
2019-09-06 |
The University Of Chicago |
Methods and composition for neutralization of influenza
|
|
CA3096703A1
(en)
|
2018-05-03 |
2019-11-07 |
University Of Rochester |
Anti-influenza neuraminidase monoclonal antibodies and uses thereof
|
|
EP3841110A1
(en)
|
2018-08-23 |
2021-06-30 |
Vanderbilt University |
Human monoclonal antibodies to a new universal influenza a hemagglutinin head domain epitope
|
|
CN111423507B
(zh)
|
2019-01-10 |
2022-04-15 |
中国科学院分子细胞科学卓越创新中心 |
广谱性中和流感病毒的全人抗体
|
|
KR20210126641A
(ko)
|
2019-02-12 |
2021-10-20 |
리제너론 파아마슈티컬스, 인크. |
보체 및 표적 항원에 결합하기 위해 이중 특이적 항체를 사용하는 조성물 및 방법
|
|
US11230593B2
(en)
|
2019-03-25 |
2022-01-25 |
Visterra, Inc. |
Compositions and methods for treating and preventing influenza
|
|
WO2020221450A1
(en)
|
2019-04-30 |
2020-11-05 |
Humabs Biomed Sa |
Antibodies and methods for treatment of influenza a infection
|
|
JP7634231B2
(ja)
|
2019-05-31 |
2025-02-21 |
ワシントン ユニバーシティ |
Ｐａｎ－ノイラミニダーゼ阻害抗体
|
|
US20220298230A1
(en)
|
2019-06-11 |
2022-09-22 |
The Rockefeller University |
Antibodies and methods for treatment of viral infections
|
|
US11053724B2
(en)
|
2019-07-23 |
2021-07-06 |
Tony AWAD |
Device to assist in closing doors
|
|
US11448049B2
(en)
|
2019-09-05 |
2022-09-20 |
Flowco Production Solutions, LLC |
Gas assisted plunger lift control system and method
|
|
IL292353A
(en)
|
2019-10-28 |
2022-06-01 |
Regeneron Pharma |
Anti-haemagglutinin antibodies and methods of using them
|
|
JP2023512684A
(ja)
|
2020-02-03 |
2023-03-28 |
ヴィア・バイオテクノロジー・インコーポレイテッド |
Ｓａｒｓ－ｃｏｖ－２に対する抗体およびそれを使用する方法
|
|
EP4100054A4
(en)
*
|
2020-02-07 |
2024-07-17 |
Washington University |
PROTECTIVE ANTIBODIES AGAINST INFLUENZA B
|
|
JP2023519105A
(ja)
|
2020-02-11 |
2023-05-10 |
ヴァンダービルト ユニバーシティ |
重症急性呼吸器症候群コロナウイルス２（ｓａｒｓ－ｃｏｖ－２）に対するヒトモノクローナル抗体
|
|
EP4107169A4
(en)
|
2020-02-18 |
2024-07-17 |
The University of North Carolina at Chapel Hill |
CAPSID-AAV PROMOTER INTERACTIONS AND CELL SELECTIVE GENE EXPRESSION
|
|
TWI818236B
(zh)
|
2020-02-19 |
2023-10-11 |
美商聯合生物醫學公司 |
用於檢測、預防和治療新型冠狀病毒(covid-19)疾病的設計胜肽及蛋白質
|
|
CN111704665B
(zh)
|
2020-02-20 |
2022-04-01 |
南京农业大学 |
一种针对H3N2犬流感病毒的重组犬源化抗体scFv-Fc
|
|
BR112022017048A2
(pt)
|
2020-02-26 |
2022-11-16 |
Vir Biotechnology Inc |
Anticorpos contra sars-cov-2 e métodos para usar os mesmos
|
|
MX2022011142A
(es)
|
2020-03-09 |
2022-12-13 |
Abcellera Biologics Inc |
Anticuerpos anti-coronavirus y metodos de uso.
|
|
US11365239B2
(en)
|
2020-03-20 |
2022-06-21 |
Tsb Therapeutics (Beijing) Co., Ltd. |
Anti-SARS-COV-2 antibodies and uses thereof
|
|
CN111303280B
(zh)
|
2020-03-22 |
2022-01-07 |
中国人民解放军军事科学院军事医学研究院 |
高中和活性抗SARS-CoV-2全人源单克隆抗体及应用
|
|
AU2021244774A1
(en)
|
2020-03-23 |
2022-09-29 |
Monash University |
Antisense oligomers for treatment of disease
|
|
WO2021195326A1
(en)
|
2020-03-26 |
2021-09-30 |
Vanderbilt University |
Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (sars-cov-2)
|
|
HRP20240182T1
(hr)
|
2020-03-26 |
2024-04-26 |
Vanderbilt University |
Ljudska monoklonska protutijela za teški akutni respiratorni sindrom koronavirusa 2 (sars-cov-2)
|
|
US20230122364A1
(en)
|
2020-03-27 |
2023-04-20 |
Vanderbilt University |
HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2)
|
|
KR20250107297A
(ko)
|
2020-04-02 |
2025-07-11 |
리제너론 파아마슈티컬스, 인크. |
항-sars-cov-2 스파이크 당단백질 항체 및 항원-결합 단편
|
|
US20230158125A1
(en)
|
2020-04-20 |
2023-05-25 |
Sorrento Therapeutics, Inc. |
Pulmonary Administration of ACE2 Polypeptides
|
|
JP2023537470A
(ja)
|
2020-08-03 |
2023-09-01 |
ヤンセン バイオテツク，インコーポレーテツド |
ウイルス治療における多方向バイオ輸送のための材料及び方法
|
|
WO2022075667A1
(ko)
|
2020-10-05 |
2022-04-14 |
한양대학교 산학협력단 |
안정화된 ace2 변이체, 이를 이용한 ace2-fc 융합단백질 및 covid-19 예방 또는 치료용 약학 조성물
|
|
EP4228697A4
(en)
|
2020-10-16 |
2025-01-01 |
Invisishield Technologies Ltd. |
Compositions for preventing or treating viral and other microbial infections
|